ALPS Medical Breakthroughs ETF
SBIOETF · NYSE Arca
$56.25
+$0.16 (+0.29%)
EOD Oct 29, 2026
Key facts
- Expense ratio
- 0.5%
- Dividend yield (TTM)
- 0.00%
- Distributions
- Annual
- Fund net assets (May 2026)
- $162M
- Stocks held
- 82
- Other positions
- 3
- Turnover (last fiscal year)
- 58%
- 52-week range
- $43.10 to $70.85
Top 10 holdings
All holdings34.8% of assets in ten stocks, as of May 31, 2026
| Company | Weight | Quality |
|---|---|---|
| 4.48% | 40 | |
| 4.23% | 25 | |
| 3.92% | n/a | |
| 3.90% | 30 | |
| 3.68% | 10 | |
| 3.35% | 40 | |
| 2.93% | n/a | |
| 2.90% | 10 | |
| 2.77% | 45 | |
| 2.64% | 10 |
Sector allocation
Share of the fund's assets
- Healthcare99.5%
Scores of what it owns
Every holding's scoreEach holding's score, weighted by its size in the fund
3% of the fund's stock weight sits in companies with a Quality score above 75, 68% in companies below 50.
Where it invests
Stock weight by the company's home country
- United States80.2%
- Netherlands4.7%
- Cayman Islands4.7%
- Ireland4.5%
- Canada2.9%
- Belgium1.2%
- United Kingdom1.1%
- Switzerland0.8%
Growth of $10,000
With and without the dividends reinvested
Dividend
Dividend historySBIO has not paid a dividend in the last twelve months; the last payment was ex-dividend Dec 19, 2024.
Average annual returns
Total return at net asset value, to May 31, 2026, as reported to the SEC
| 1 year | 5 years | 10 years |
|---|---|---|
| 87.52% | 3.85% | 8.81% |
Past returns say nothing certain about future ones.
SBIO questions
What does SBIO invest in?+
ALPS Medical Breakthroughs ETF is an exchange-traded fund. Its largest holdings are Alkermes plc (4.48%), Kymera Therapeutics Inc. (4.23%), Celcuity Inc. (3.92%).
What is SBIO's expense ratio?+
0.5% a year, as stated in the fund's latest shareholder report filed with the SEC. On a $10,000 investment that is about $50.00 a year.
How good are the companies SBIO owns?+
Weighted by position size, the stocks in SBIO average a Quality score of 28 out of 100. 3% of the fund's stock weight sits in companies scoring above 75, 68% in companies below 50. The score is computed from each company's SEC filings; the methodology page lists every check.
Holdings: the fund's latest SEC Form N-PORT, as of May 31, 2026. Expense ratio, turnover and returns: the fund's shareholder report (SEC Form N-CSR) for the period to May 31, 2026. Net assets: SEC Form N-PORT. Quality scores: computed by Intrinsiqq from each company's SEC filings (methodology). Price: end of day Oct 29, 2026.